Literature DB >> 33563813

Quality of life in isolated dystonia: non-motor manifestations matter.

Johanna Junker1,2, Brian D Berman3, James Hall4, Deena W Wahba5, Valerie Brandt6, Joel S Perlmutter7, Joseph Jankovic8, Irene A Malaty9, Aparna Wagle Shukla9, Stephen G Reich10, Alberto J Espay11, Kevin R Duque11, Neepa Patel12, Emmanuel Roze13,14, Marie Vidailhet13,14, H A Jinnah15, Norbert Brüggemann16,2,17.   

Abstract

OBJECTIVE: To evaluate the relationship between health-related quality of life (HR-QoL) and both physical and psychiatric factors in a large, international, multicentre cohort of patients with isolated dystonia, the Dystonia Coalition.
METHODS: Natural history data from 603 patients with isolated dystonia (median age 57 years (IQR: 48 to 64 years), 67.0% women) were prospectively acquired and analysed. HR-QoL (RAND 36-Item Health Survey), severity of depressive symptoms, generalised anxiety (Hospital Anxiety and Depression Scale) and social anxiety (Liebowitz Social Anxiety Scale) were assessed. Dystonia severity (Burke-Fahn-Marsden Dystonia Rating Scale) and dystonic tremor were examined. Statistical predictors of HR-QoL were calculated using saturated path analysis.
RESULTS: Reduced HR-QoL was strongly associated with the degree of depressive symptoms and generalised and social anxiety (8/8 RAND 36 subscales, p≤0.001). Increased dystonia severity was associated with worse physical functioning, physical and emotional role functioning and social functioning (all p≤0.001). The presence of tremor correlated with worse physical functioning and pain (all p≤0.006). Younger age was associated with reduced emotional well-being and vitality (all p≤0.006). There were no HR-QoL differences between sexes.
CONCLUSION: HR-QoL in isolated dystonia is strongly associated with psychiatric and physical features. While current standard of care focus on motor aspects of dystonia, comprehensive care should address both physical and mental aspects of health. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Year:  2021        PMID: 33563813      PMCID: PMC8356023          DOI: 10.1136/jnnp-2020-325193

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   13.654


  45 in total

Review 1.  Dystonia.

Authors:  Bettina Balint; Niccolò E Mencacci; Enza Maria Valente; Antonio Pisani; John Rothwell; Joseph Jankovic; Marie Vidailhet; Kailash P Bhatia
Journal:  Nat Rev Dis Primers       Date:  2018-09-20       Impact factor: 52.329

2.  Secured web-based video repository for multicenter studies.

Authors:  Ling Yan; Matt Hicks; Korey Winslow; Cynthia Comella; Christy Ludlow; H A Jinnah; Ami R Rosen; Laura Wright; Wendy R Galpern; Joel S Perlmutter
Journal:  Parkinsonism Relat Disord       Date:  2015-01-20       Impact factor: 4.891

3.  Evaluation of the quality of life in patients with segmental dystonia.

Authors:  Natasa Basurović; Marina Svetel; Tatjana Pekmezović; Vladimir S Kostić
Journal:  Vojnosanit Pregl       Date:  2012-09       Impact factor: 0.168

4.  Prevalence of non-motor symptoms and their association with quality of life in cervical dystonia.

Authors:  Vladimir Han; Matej Skorvanek; Marenka Smit; Monika Turcanova Koprusakova; Tialda Hoekstra; Jitse P van Dijk; Marina A J Tijssen; Zuzana Gdovinova; Sijmen A Reijneveld
Journal:  Acta Neurol Scand       Date:  2020-07-13       Impact factor: 3.209

5.  Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysis.

Authors:  Takashi Tsuboi; James H Cauraugh; Joshua K Wong; Michael S Okun; Adolfo Ramirez-Zamora
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-07-30       Impact factor: 10.154

6.  Quality of life in patients with focal dystonia.

Authors:  Tatjana Pekmezovic; Marina Svetel; Natasa Ivanovic; Natasa Dragasevic; Igor Petrovic; Darija Kisic Tepavcevic; Vladimir S Kostic
Journal:  Clin Neurol Neurosurg       Date:  2008-11-07       Impact factor: 1.876

7.  Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD).

Authors:  Jordi Alonso; Jean-Pierre Lépine
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

8.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

9.  Psychiatric disorders in adult-onset focal dystonia: a case-control study.

Authors:  Giovanni Fabbrini; Isabella Berardelli; Germana Moretti; Massimo Pasquini; Maria Bloise; Carlo Colosimo; Massimo Biondi; Alfredo Berardelli
Journal:  Mov Disord       Date:  2010-03-15       Impact factor: 10.338

10.  Quality of life in idiopathic dystonia: a systematic review.

Authors:  Ayesha Girach; Ana Vinagre Aragon; Panagiotis Zis
Journal:  J Neurol       Date:  2018-11-20       Impact factor: 4.849

View more
  3 in total

1.  Health-Related Quality of Life in Cervical Dystonia Using EQ-5D-5L: A Large Cross-Sectional Study in China.

Authors:  Yan Liang; Junyu Lin; Yanbing Hou; Lingyu Zhang; Ruwei Ou; Chunyu Li; Qianqian Wei; Bei Cao; Kuncheng Liu; Zheng Jiang; Tianmi Yang; Jing Yang; Meng Zhang; Simin Kang; Yi Xiao; Qirui Jiang; Jing Yang; Wei Song; Xueping Chen; Bi Zhao; Ying Wu; Huifang Shang
Journal:  Front Neurol       Date:  2022-06-23       Impact factor: 4.086

2.  Adult-onset idiopathic dystonia: A national data-linkage study to determine epidemiological, social deprivation, and mortality characteristics.

Authors:  Grace A Bailey; Anna Rawlings; Fatemeh Torabi; Owen Pickrell; Kathryn J Peall
Journal:  Eur J Neurol       Date:  2021-10-15       Impact factor: 6.288

3.  Individual Response to Botulinum Toxin Therapy in Movement Disorders: A Time Series Analysis Approach.

Authors:  Bernd Leplow; Johannes Pohl; Julia Wöllner; David Weise
Journal:  Toxins (Basel)       Date:  2022-07-24       Impact factor: 5.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.